A

Adocia SA
PAR:ADOC

Watchlist Manager
Adocia SA
PAR:ADOC
Watchlist
Price: 8.2 EUR -4.98% Market Closed
Market Cap: 149.9m EUR

EV/EBIT
Enterprise Value to EBIT

-20.4
Current
-12.9
Median
5.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-20.4
=
Enterprise Value
150.9m EUR
/
EBIT
-7.4m EUR
EBIT Growth EV/EBIT to Growth
FR
A
Adocia SA
PAR:ADOC
Average EV/EBIT: 18.8
Negative Multiple: -20.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 287.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.9
28%
0.9
US
U
US BioTec Inc
OTC:USBC
Not Available N/A N/A
US
Amgen Inc
NASDAQ:AMGN
18.8
19%
1
US
Gilead Sciences Inc
NASDAQ:GILD
14.8
12%
1.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.5 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.6
17%
1.3
AU
CSL Ltd
ASX:CSL
19.2
16%
1.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.6
10%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -328.9 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
2.7
2-Years Forward
EV/EBIT
3.2
3-Years Forward
EV/EBIT
N/A